StonvexLoading…
StonvexStonvexStonvexCore line items from FCF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $632.69M | $600.46M | $530.00M | $329.95M |
Operating Income | $191.36M | $178.21M | $197.56M | $160.19M |
Net Income | $152.30M | $142.57M | $157.06M | $128.18M |
EPS (Diluted) | $1.47 | $1.39 | $1.54 | $1.37 |
Total Assets | $12.34B | $11.58B | $11.46B | $9.81B |
Total Liabilities | $10.79B | $10.18B | $10.15B | $8.75B |
Cash & Equivalents | $180.36M | $133.41M | $146.99M | $154.24M |
Free Cash Flow OCF − CapEx | $171.45M | $113.92M | $128.72M | $140.21M |
Shares Outstanding | 102.84M | 101.76M | 102.11M | 93.38M |